BehaVR, formed by the merger of Nashville-based BehaVR and OxfordVR, builds evidence-based immersive digital therapeutics delivered on an integrated platform. The combined company will operate under the BehaVR brand and is led by CEO Aaron Gani. Its suite of clinically validated therapeutics spans mental wellness and mental and behavioral conditions, including validated treatments for serious mental illness. The platform simplifies the patient experience, enables clinician oversight, and generates patient-specific care plans and measurable outcomes. OxfordVR's gameChange product has been granted FDA Breakthrough Device designation and will deliver automated cognitive-behavioral VR therapy that can be administered by clinical staff, peer group members, or at home.

Total raised

$13M

Funding rounds

1

Latest round

Series B

Latest activity

Dec 2022